Literature DB >> 7282128

Breeding of nude mice under improved conventional conditions.

H Naundorf, W Arnold.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7282128

Source DB:  PubMed          Journal:  Z Versuchstierkd        ISSN： 0044-3697


× No keyword cloud information.
  6 in total

1.  Establishment and characteristics of two new human mammary carcinoma lines serially transplantable in nude mice.

Authors:  H Naundorf; I Fichtner; G J Saul; W Haensch; B Büttner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Establishment and characterization of a new human oestradiol- and progesterone-receptor-positive mammary carcinoma serially transplantable in nude mice.

Authors:  H Naundorf; I Fichtner; B Büttner; J Frege
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Establishment and characteristics of two new human mammary carcinoma lines in nude mice with special reference to the estradiol receptor status and the importance of stroma for in vivo and in vitro growth.

Authors:  H Naundorf; I Fichtner; B Elbe; G J Saul; W Haensch; W Zschiesche; S Reinecke
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Development and characterization of a tamoxifen-resistant breast carcinoma xenograft.

Authors:  H Naundorf; M Becker; A E Lykkesfeldt; B Elbe; C Neumann; B Büttner; I Fichtner
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

5.  Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives.

Authors:  H Naundorf; E C Rewasowa; I Fichtner; B Büttner; M Becker; M Görlich
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.624

6.  Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas.

Authors:  H Naundorf; K Parczyk; W Zschiesche; S Reinecke; B Büttner; G J Saul; B Sinn; I Fichtner
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.